Reis Roberta Albino Dos, de Freitas Carolina C, da Silva Leonardo Longuini, Monteiro Laura Pierobão, Nakazato Gerson, Champeau Mathilde, da Silva Ricardo A Galdino, Seabra Amedea Barozzi
Centro de Ciências Naturais e Humanas (CCNH), Universidade Federal do ABC (UFABC), Santo André 09210-580, SP, Brazil.
Laboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, Brazil.
Antibiotics (Basel). 2025 Sep 3;14(9):891. doi: 10.3390/antibiotics14090891.
Chitosan-based films incorporating green-synthesized silver nanoparticles AgNPs) or copper oxide nanoparticles (CuONPs) were developed to compare their selective antimicrobial action for topical applications. While AgNPs are known for broad-spectrum activity, this study hypothesized that CuONPs would exhibit superior, targeted efficacy against the acne-associated bacterium . Nanoparticles were synthesized using Camellia sinensis extract and characterized. Antimicrobial activity was evaluated using Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) assays. Chitosan films containing AgNPs or CuONPs were further tested for selective antimicrobial activity and fibroblast cytocompatibility. AgNPs showed strong activity against and (MIC = 15 µg/mL) but were less effective against (MIC = 125 µg/mL). In contrast, CuONPs demonstrated selective efficacy against (MIC = 62 µg/mL; MBC = 125 µg/mL). When incorporated into chitosan films, AgNPs@CHI inhibited (35 mm halo) and (30 mm), whereas CuONPs@CHI were selectively effective against (45 mm). All films preserved fibroblast viability above the 70% ISO 10993-5 threshold. CuONPs@CHI films validated selective anti-C. acnes performance, highlighting their promise for targeted anti-acne therapies, while AgNPs@CHI films served as effective broad-spectrum antimicrobial barriers.revealed that AgNPs were potent against and (MIC = 15 µg/mL) but less effective against (MIC = 125 µg/mL). Conversely, CuONPs demonstrated a marked selective advantage against (MIC = 62 µg/mL; MBC = 125 µg/mL). When incorporated into chitosan films, AgNPs@CHI films inhibited (35 mm halo) and (30 mm), whereas CuONPs@CHI films were selectively effective only against (45 mm), confirming the targeted performance. All films maintained fibroblast viability above the 70% ISO 10993-5 cytotoxicity threshold. These findings validate the selective action of CuONPs@CHI films, positioning them as a promising biomaterial for targeted anti-acne therapies, while AgNPs@CHI films serve as effective broad-spectrum antimicrobial barriers.
开发了含有绿色合成银纳米颗粒(AgNPs)或氧化铜纳米颗粒(CuONPs)的壳聚糖基薄膜,以比较它们在局部应用中的选择性抗菌作用。虽然AgNPs以广谱活性而闻名,但本研究假设CuONPs对痤疮相关细菌将表现出卓越的靶向疗效。使用茶树提取物合成纳米颗粒并进行表征。使用最低抑菌浓度(MIC)和最低杀菌浓度(MBC)测定法评估抗菌活性。进一步测试了含有AgNPs或CuONPs的壳聚糖薄膜的选择性抗菌活性和成纤维细胞的细胞相容性。AgNPs对金黄色葡萄球菌和大肠杆菌表现出较强的活性(MIC = 15μg/mL),但对痤疮丙酸杆菌的效果较差(MIC = 125μg/mL)。相比之下,CuONPs对痤疮丙酸杆菌表现出选择性疗效(MIC = 62μg/mL;MBC = 125μg/mL)。当掺入壳聚糖薄膜中时,AgNPs@CHI抑制金黄色葡萄球菌(晕圈35mm)和大肠杆菌(30mm),而CuONPs@CHI对痤疮丙酸杆菌具有选择性效果(45mm)。所有薄膜均能使成纤维细胞活力保持在ISO 10993-5规定的70%阈值以上。CuONPs@CHI薄膜验证了其对痤疮丙酸杆菌的选择性抗菌性能,突出了它们在靶向抗痤疮治疗中的潜力,而AgNPs@CHI薄膜则作为有效的广谱抗菌屏障。研究表明,AgNPs对金黄色葡萄球菌和大肠杆菌具有强效作用(MIC = 15μg/mL),但对痤疮丙酸杆菌效果较差(MIC = 125μg/mL)。相反,CuONPs对痤疮丙酸杆菌表现出显著的选择性优势(MIC = 62μg/mL;MBC = 125μg/mL)。当掺入壳聚糖薄膜中时,AgNPs@CHI薄膜抑制金黄色葡萄球菌(晕圈35mm)和大肠杆菌(30mm),而CuONPs@CHI薄膜仅对痤疮丙酸杆菌具有选择性效果(45mm),证实了其靶向性能。所有薄膜均能使成纤维细胞活力保持在ISO 10993-5细胞毒性阈值的70%以上。这些发现验证了CuONPs@CHI薄膜的选择性作用,使其成为靶向抗痤疮治疗中有前景的生物材料,而AgNPs@CHI薄膜则作为有效的广谱抗菌屏障。